Venlafaxine HCl extended-release capsules, indicated for the treatment of major depressive disorder and generalized anxiety disorder, are the generic version of Wyeth Pharmaceutical’s Effexor XR capsules. Currently, Mylan
This agreement establishes MedX as the exclusive provider of low level laser and light technology to Naimco/Rich-Mar and will allow MedX Health to sell components to Naimco/Rich-Mar that
The alliance between Patheon and Senopsys is intended to deliver patient accepted pediatric formulations, line extension products and reformulated pharmaceutical products. These products will be optimized for palatability
Sorin Group and Sphere Medical have undertaken a feasibility study which included an evaluation of Sphere Medical’s microsensor technology in animal and human blood. Following the successful conclusion
Abingdon will utilize the resources of Stason Pharma Japan to enhance its business development and intellectual property licensing opportunities in Asia. Abingdon will also offer strategic planning, clinical
The Freedom-C trial was a randomized, double-blind, placebo-controlled trial of patients with severe pulmonary arterial hypertension (PAH). The study population consisted of 354 patients who were optimized on
Under the terms of the agreements, United Therapeutics will make an upfront payment of $150 million to Lilly for the exclusive rights to commercialize tadalafil for pulmonary arterial
By combining Philips Research’s strengths in microelectronics, signal processing, ultra-low power system design and miniaturization with NeuroNexus Technologies’s expertise in micro-scale electrode design and fabrication, the two companies
Under the terms of this relationship, HnG Medical will represent and negotiate medical coating services and royalty/fee based license agreements in China. In addition to the urinary catheter
New data from a multi-center clinical trial led by investigators at Johns Hopkins School of Medicine demonstrate that use of the ErecAid vacuum erection device to augment PDE5i
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.